Image of drosophila larval body with staining

Mutant lamins cause abnormal nuclear shape in muscle. Drosophila larval body wall muscles (magenta) expressing mutant lamins (green) have abnormally shaped nuclei. (Blue indiciates genomic DNA.) In humans, the same mutant lamin causes a rare type of muscular dystrophy.

Image of drosophila imaginal eye/antennal disc with staining

Mutant Snrnp200 causes cell death in the eye. A Drosophila imaginal eye/antennal disc expressing mutant Snrnp200 show staining with an antibody to a cell death marker (green). (Red indicates differentiated photoreceptors; Blue indicates genomic DNA). In humans, the same mutation causes Retinitis Pigmentosa, a rare vison disorder.

Rare types of muscular dystrophy:

Mutations in the human LMNA gene cause a collection of diseases called laminopathies, such as muscular dystrophies, heart disease, adipose tissues disorders, and early onset aging syndromes. The LMNA gene encodes lamins, intermediate filaments that form a meshwork lining the inner nuclear membrane. Lamins provide structural support for the nucleus and play roles in genome organization, gene expression, and DNA repair. The mechanisms by which mutant lamins cause laminopathies are not well understood and there are currently no therapies. Members of the Wallrath laboratory are investigating the molecular basis of muscular dystrophies and have developed Drosophila (fruit fly) models, which provide ease of genetic and cytological analyses. Human muscle biopsy tissue is used to demonstrate disease relevance of the findings. Their studies have identified signaling pathways altered by mutant lamins and compounds that improve muscle function, providing potential new avenues for therapies.

Rare type of eye disease:

Mutations in genes encoding pre-mRNA splicing factors cause Retinitis Pigmentosa, a vision disorder characterized by progressive loss of photoreceptor function and ultimately blindness. Members of the Wallrath lab are investigating mutations in the SNRNP200 gene encoding a core pre-mRNA splicing factor that possess RNA helicase activity. They have developed Drosophila (fruit fly) models of this disease and found that the flies recapitulate many aspects of the human eye disease, including progressive loss of photoreceptor function. These models are currently being used to understand the pathophysiology of the eye disease and for genetic and pharmacological screens to identify potential therapies.

group lab photo

Wallrath Lab, Fall 2023

(back row, left to right) Brenna Powers (BMB Major), Hailey McCoy-Munger (Biomedical Engineering Major), Sara Mayer (Genetics PhD candidate); (front row, left to right) Paige Wiebke (BMB Major), Lori Wallrath (BMB Professor), Nathan Mohar (Genetics PhD candidate)

Selected Publications

Walker, S.G., Langland, C.J., Viles, J., Hecker, L.A., and Wallrath, L.L. (2023) Drosophila models reveal properties of mutant lamins that give rise to distinct diseases. Cells 12:1142 doi: 10.3390/cells12081142

Shaw, N.M., Rios-Monterrosa, J.L., Fedorchak, G.R., Ketterer M.R., Coombs, G.S., Lammerding, J., and Wallrath, L.L. (2022) Effects of mutant lamins on nucleo-cytoskeletal coupling in Drosophila models of LMNA muscular dystrophy. Front. Cell. Dev. Biol. doi: 10.3389/fcell.2002.934586

Coombs, G.S., Rios-Monterrosa, J.L., Lai, S., Dai, Q., Goll, A.C., Ketterer, M.R., Valdes, M.F., Uche, N., Benjamin, I.J. and Wallrath, L.L. (2021) Modulation of muscle redox and protein aggregation reduces lethality cause by mutant lamins. Redox Biol. 48:102196 doi:10.1016/j.redox.2021.102196

Hinz, B.E., Walker, S.G., Xiong, A. Gogal, R.A., Schnieders, M.J. and Wallrath, L.L. (2021) In silico and in vivo analysis of amino acid substitutions that cause laminopathies. Int. J. Mol. Sci. 22:11226 doi:10.3390/ijms222011226

Events

College of Pharmacy PSET Seminar Series: Leslie Benet, PhD promotional image

College of Pharmacy PSET Seminar Series: Leslie Benet, PhD

Tuesday, November 18, 2025 11:30am
College of Pharmacy Building

The Department of Pharmaceutical Sciences and Experimental Therapeutics (PSET) in the College of Pharmacy will host a seminar presented by: 

Leslie Benet, PhD
Professor
Department of Bioengineering & Therapeutic Sciences
University of California San Francisco
San Francisco, California

All are welcome to attend. No pre-registration required.

Seminar Title: "Simplifying the Application and Teaching of Clinical Pharmacokinetics"

College of Pharmacy PSET Seminar Series: Robin Bogner, PhD

Tuesday, December 2, 2025 11:30am
College of Pharmacy Building

The Department of Pharmaceutical Sciences and Experimental Therapeutics (PSET) in the College of Pharmacy will host a seminar presented by: 

Robin Bogner, PhD
Director, Kildsig Center for Pharmaceutical Processing Research (CPPR)
Department of Pharmaceutical Sciences
University of Connecticut
Storrs, Connecticut

All are welcome to attend. No pre-registration required.

College of Pharmacy PSET Seminar Series: Matthew Caporizzo, PhD

Tuesday, December 9, 2025 11:30am
College of Pharmacy Building

The Department of Pharmaceutical Sciences and Experimental Therapeutics (PSET) in the College of Pharmacy will host a seminar presented by: 

Matthew Caporizzo, PhD
Assistant Professor
Molecular Physiology and Biophysics
The University of Vermont
Burlington, Vermont

All are welcome to attend. No pre-registration required.

View more events

Contact Information

 

Lori Wallrath, PhD
Professor of Biochemistry and Molecular Biology
Carver College of Medicine
University of Iowa
375 Newton Rd, 3136 MERF
Iowa City, IA 52242

lori-wallrath@uiowa.edu